晚期糖基化终产物在口腔鳞状细胞癌发展及治疗的研究进展
王文轩,刘云坤,李冰芷,黄能文,侯泽宇,唐金茹,李龙江
国际口腔医学杂志 ›› 2024, Vol. 51 ›› Issue (2) : 208 -216.
晚期糖基化终产物在口腔鳞状细胞癌发展及治疗的研究进展
Role of advanced glycosylation end-products and their receptors in the progression and treatment of oral squamous cell carcinoma
了解口腔鳞状细胞癌(OSCC)发生、发展的分子机制仍然是认识OSCC恶性生物学特点及探索针对性治疗方法的研究热点。晚期糖基化终末产物(AGE)及其受体RAGE与其他受体在体内相互作用,从而激活多个信号通路,诱导白细胞介素、生长因子和细胞因子的合成。近期的研究表明,AGE/RAGE相关信号传导通路的激活影响OSCC的增殖、侵袭、血管生成、局部复发,与晚期OSCC症患者的预后不良有关。本文对AGE/RAGE与OSCC恶性演进进行综述,以期为OSCC治疗提供潜在靶点。
The molecular mechanisms underlying the occurrence and progression of oral squamous cell carcinoma (OSCC) are still not fully understood. This topic remains a focal point of research to comprehend the malignant biological characteristics of OSCC and explore targeted therapeutic approaches. Advanced glycation end-products (AGEs) and their receptors (RAGE) interact with other receptors in vivo, thereby activating multiple signaling pathways to induce the synthesis of interleukins, growth factors, and cytokine synthesis. Recent studies have shown that the activation of AGE/RAGE-related signaling pathways affects the proliferation, invasion, angiogenesis, and local recurrence of oral cancer and is associated with poor prognosis in patients with advanced oral cancer. This paper reviews the relationship between AGEs/RAGE and OSCC with the aim of providing potential targets for OSCC treatment.
口腔鳞状细胞癌 / 晚期糖基化终产物 / 晚期糖基化终末产物受体
oral squamous cell carcinoma / advanced glycation end-product / receptor of advanced glycation end-product
王文轩,硕士,Email:
/
〈 |
|
〉 |